The Week In Biopharma, July 4 – 8
Contract Research (CROs)
- Care Access buys Brazilian research firm as part of regional expansion (USA)
- ClinChoice raises $150M in series E round as CRO outlines growth plan and potential IPO (USA)
- Eurofins Discovery Announces Acquisition of DiscoveryBioMed (UK)
Contract Development and Manufacturing (CDMO)
- Sinopharm considering $1B buy for Shanghai-based DNA maker BBI Life Sciences: report (China)
- Catalent Enters Clinical Manufacturing Deal with Xenetic Bioscienes (USA)
- Wasdell Group Expands Clinical Capabilities (UK)
- LASEROPTEK Co. Ltd., and Monarch Lasers Sign a Multi-Year Exclusive Distribution Agreement for the United States Medical Aesthetic Market (South Korea/USA)
- Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction (USA)
- Calyxo hoovers up $32M for vacuum-assisted device to remove kidney stone fragments (USA)
- Exothera Forms Vaccine Manufacturing Partnership with Vaccizone (Belgium/Turkey)
- Qualigen Enters Manufacturing Agreement with Hande Sciences (USA/China)
- WuXi STA Opens Oligonucleotide and Peptide Manufacturing Facility (China)
- Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS variant (The Netherlands)
- Exyte Builds mRNA Competence Center for WACKER in Halle (Germany)
- Bio-Techne Announces Completion of Namocell Acquisition (USA)
- Sharp Expands Clinical Services Operations at Heerenveen Facility (the Netherlands)
- WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products (China)
- TCG Lifesciences inaugurates a new R&D facility in Pune, as part of a major expansion (India)
Biopharma
- Adverum Slashes Workforce By 38%, Hones In On Eye Disease Candidate (USA)
- REGENXBIO Announces Enrollment Complete in Cohort 5 of Phase II AAVIATE® Trial (USA)
- CASI pockets $5M for autoimmune drug deal as China’s Precision secures $21M funding (China)
- Sobi to license loncastuximab tesirine from ADC Therapeutics (Sweden/Switzerland)
- Dynacure Axes Investigational Study of CNM Treatment (France)
- Nurix Therapeutics Announces $40 Million Registered Direct Offering (USA)
- FDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy (Ireland)
- Annovis Bio Announces Positive FDA Notice For Buntanetap Phase 3 Clinical Trial In Parkinson’s Disease (USA)
- Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology (USA)
- Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines (China)
- Provention Bio Announces $60 Million Private Placement (USA)
- Portage raids fellow biotech Tarus for adenosine receptor treasures (Canada)
- Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies (USA/Poland)
- Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, (UK)
- OBI Pharma culls early cancer asset as it focuses on later-stage bets (Taiwan)
- BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies (China)
- Nordic Nanovector finally throws in the towel (Norway)
- Evotec, Boehringer Ingelheim and BioMérieux Form Joint Venture (Germany/ France)
- KBI Biopharma, Selexis Open State-of-the-Art Facility in Geneva (Switzerland)
- Plakous Therapeutics Announces New Funding to Support Development of Therapies for Necrotizing Enterocolitis (USA)
- Unravel Biosciences Partners with TMA Precision Health to Advance Drug Treatment for Rett Syndrome into the Clinic (USA)
- EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement (Japan)
- Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss (UK/Japan)
- Iveric taps DelSiTech to develop sustained-release form of retinal disease prospect (USA)
- After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement (Germany)
- Codiak gets $2.5M from CEPI to forge way out of pandemic, prep for disease X (USA)
- Syros inks $190M merger, Flagship-backed financing to extend cash runway into 2025 (USA)
- Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets (USA/France)
- AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline (UK)
Artificial Intelligence
- Roche, EarlySign expand partnership to include AI-powered lung cancer diagnosis (Switzerland/Israel)
- Unilabs Sweden Launches Subtle Medical’s AI-powered Imaging Technology to Further Bolstering Patient Care (Switzerland/USA)
- AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning (USA)
- Fairtility welcomes EU approval for embryo assessment AI (Israel)
